Colitis ulcerosa: vizsgálatok itt: Horvátország
13 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 11.. Ask the study team whether a trial fits you.
- 2. fázisTaking peopleAn Adaptive, Dose-Ranging, Phase 2 Study of Eltrekibart Given Alone or in Combination with Mirikizumab for the Treatment of Adult Patients with Moderately to Severely Active Ulcerative Colitis
- Where
- Bjelovar, Grad Zagreb, Osijek, Rijeka, Slavonski Brod, Zagreb
- Életkor
- 18 év and over
- People
- 587 worldwide
- Run by
- Eli Lilly & Co.
See details and how to join2023-507853-13-00 · EU 2023-507853-13-00 - 2. fázisCsak meghívásosLong-term Safety and Efficacy of Multiple Long-acting Antibodies Alone and in Combinations for IBD
- Where
- Osijek, Zagreb
- Életkor
- 18 év and over
- People
- 645 worldwide
- Run by
- Spyre Therapeutics, Inc.
See details and how to joinNCT07652294 · EU 2025-524640-35-00 - 2. fázisTaking peopleLY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
- Where
- Bjelovar, Osijek, Split, Zagreb
- Életkor
- 18 év to 80 év
- People
- 1431 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07415044 - 1/2. fázisTaking peopleStudy of XmAb942 in Healthy Participants and Participants With Ulcerative Colitis
- Where
- Osijek, Rijeka, Zagreb
- Életkor
- 18 év to 75 év
- People
- 270 worldwide
- Run by
- Xencor, Inc.
See details and how to joinNCT06619990 - 2. fázisTaking peopleA Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
- Where
- Osijek, Zagreb
- Életkor
- 18 év to 75 év
- People
- 645 worldwide
- Run by
- Spyre Therapeutics, Inc.
See details and how to joinNCT07012395 · EU 2025-521242-26-00 - 3. fázisTaking peopleA study evaluating the effects of filgotinib in children and teenagers with ulcerative colitis
- Where
- Osijek, Zagreb
- Életkor
- Up to 17 év
- People
- 68 worldwide
- Run by
- Alfasigma S.p.A.
See details and how to join2024-511458-32-00 · EU 2024-511458-32-00 - 2. fázisTaking peopleA study of LY4268989 in participants with Moderately to Severely Active Ulcerative Colitis (EMERALD-3)
- Where
- Bjelovar, Osijek, Split, Zagreb
- Életkor
- 18 év and over
- People
- 104 worldwide
- Run by
- Eli Lilly & Co.
See details and how to join2025-524404-29-00 · EU 2025-524404-29-00 - 3. fázisTaking peopleA Study Evaluating the Effects of Filgotinib in Children and Teenagers With Ulcerative Colitis
- Where
- Osijek, Zagreb
- Életkor
- 8 év to 18 év
- People
- 80 worldwide
- Run by
- Alfasigma S.p.A.
See details and how to joinNCT06865417 - No phaseNot yet taking people in HorvátországThe Effects of a Modified Mediterranean Diet on Ulcerative Colitis Patients
- Where
- Zagreb
- Életkor
- 18 év and over
- People
- 62
- Run by
- University Hospital Sestre Milosrdnice
See details and how to joinNCT07857447 - 2. fázisTaking peopleA Phase 2a Study of the Safety and Efficacy of OD-07656 and of Subsequent Vedolizumab Therapy in Moderately to Severely Active Ulcerative Colitis
- Where
- Grad Zagreb, Osijek, Split
- Életkor
- 18 év and over
- People
- 70 worldwide
- Run by
- Odyssey Therapeutics Inc.
See details and how to join2024-520201-39-00 · EU 2024-520201-39-00 - 2. fázisTaking peopleA Phase 2 Platform Study to Evaluate Therapies for Inflammatory Bowel Disease
- Where
- Grad Zagreb, Osijek, Rijeka, Zagreb
- Életkor
- 18 év and over
- People
- 54 worldwide
- Run by
- Mirador Therapeutics Inc.
See details and how to join2025-522001-38-00 · EU 2025-522001-38-00 - No phaseCsak meghívásosUlcerative Colitis Permeability
- Where
- Zagreb
- Életkor
- 18 év to 70 év
- People
- 100
- Run by
- University Hospital Dubrava
See details and how to joinNCT07662902 - 3. fázisTaking peopleA Study of Vedolizumab in Children With Ulcerative Colitis (UC) or Crohn's Disease (CD)
- Where
- Grad Zagreb
- Életkor
- 2 év to 17 év
- People
- 240 worldwide
- Run by
- Takeda
See details and how to joinNCT05442567 · EU 2023-509046-36-00